X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with JUBILANT LIFE SCIENCES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs JUBILANT LIFE SCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA JUBILANT LIFE SCIENCES ELDER PHARMA/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x -0.2 19.9 - View Chart
P/BV x 0.1 4.2 2.4% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 ELDER PHARMA   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
JUBILANT LIFE SCIENCES
Mar-14
ELDER PHARMA/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs380187 203.4%   
Low Rs18865 288.8%   
Sales per share (Unadj.) Rs491.2364.3 134.8%  
Earnings per share (Unadj.) Rs-3.26.8 -46.5%  
Cash flow per share (Unadj.) Rs14.424.5 58.8%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Dividend yield (eoy) %02.4 0.0%  
Book value per share (Unadj.) Rs376.5164.9 228.3%  
Shares outstanding (eoy) m20.54159.28 12.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.60.3 167.3%   
Avg P/E ratio x-89.318.4 -485.2%  
P/CF ratio (eoy) x19.75.1 383.4%  
Price / Book Value ratio x0.80.8 98.8%  
Dividend payout %043.8 0.0%   
Avg Mkt Cap Rs m5,83320,061 29.1%   
No. of employees `000NA6.2 0.0%   
Total wages/salary Rs m2,17911,052 19.7%   
Avg. sales/employee Rs ThNM9,383.0-  
Avg. wages/employee Rs ThNM1,786.9-  
Avg. net profit/employee Rs ThNM176.3-  
INCOME DATA
Net Sales Rs m10,08958,034 17.4%  
Other income Rs m257191 134.6%   
Total revenues Rs m10,34658,224 17.8%   
Gross profit Rs m-7925,786 -13.7%  
Depreciation Rs m3612,812 12.8%   
Interest Rs m2,7563,237 85.1%   
Profit before tax Rs m-3,653-72 5,066.4%   
Minority Interest Rs m0-286 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7132,145 173.1%   
Tax Rs m125696 18.0%   
Profit after tax Rs m-651,090 -6.0%  
Gross profit margin %-7.810.0 -78.7%  
Effective tax rate %-3.4-965.9 0.4%   
Net profit margin %-0.61.9 -34.5%  
BALANCE SHEET DATA
Current assets Rs m9,24029,280 31.6%   
Current liabilities Rs m9,99838,912 25.7%   
Net working cap to sales %-7.5-16.6 45.3%  
Current ratio x0.90.8 122.8%  
Inventory Days Days4684 54.9%  
Debtors Days Days6051 118.3%  
Net fixed assets Rs m10,12455,712 18.2%   
Share capital Rs m206155 133.1%   
"Free" reserves Rs m5,58220,968 26.6%   
Net worth Rs m7,73426,265 29.4%   
Long term debt Rs m4,88917,169 28.5%   
Total assets Rs m22,88288,606 25.8%  
Interest coverage x-0.31.0 -33.3%   
Debt to equity ratio x0.60.7 96.7%  
Sales to assets ratio x0.40.7 67.3%   
Return on assets %11.84.9 240.8%  
Return on equity %-0.84.2 -20.4%  
Return on capital %22.311.6 192.9%  
Exports to sales %3.037.8 8.0%   
Imports to sales %0.416.5 2.6%   
Exports (fob) Rs m30721,933 1.4%   
Imports (cif) Rs m439,567 0.5%   
Fx inflow Rs m30722,004 1.4%   
Fx outflow Rs m12511,749 1.1%   
Net fx Rs m18110,255 1.8%   
CASH FLOW
From Operations Rs m11,7548,026 146.4%  
From Investments Rs m-561-1,744 32.1%  
From Financial Activity Rs m-6,762-4,447 152.0%  
Net Cashflow Rs m4,4321,834 241.6%  

Share Holding

Indian Promoters % 39.6 45.6 86.8%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 7.5 8.7 86.2%  
FIIs % 16.8 21.2 79.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 21.1 171.1%  
Shareholders   16,479 23,815 69.2%  
Pledged promoter(s) holding % 77.6 15.9 489.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   DIVIS LABORATORIES  GLENMARK PHARMA  AUROBINDO PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 8-QTR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS